Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo urges adoption of non-organ-specific alcohol/analgesic warning.

This article was originally published in The Tan Sheet

Executive Summary

NON-ORGAN-SPECIFIC ANALGESIC/ALCOHOL WARNING URGED BY PERRIGO in Jan. 27 comments to FDA on the agency's proposed rule calling for alcohol warnings on analgesic products. The private label manufacturer suggests that instead of FDA's proposed warnings, which are product and organ specific, the agency adopt the warning it previously recommended be voluntarily used by the OTC industry, which directs the consumer to consult a physician if he/she "generally consumes three or more alcohol-alcohol drinks per day." Allegan, Mich.-based Perrigo uses the voluntary warning on all of its acetaminophen products.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel